LVCLY logo

Living Cell Technologies Limited (LVCLY) Stock Analysis

DELISTED

What happened to Living Cell Technologies Limited (LVCLY) stock?

Living Cell Technologies Limited (LVCLY) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $11.4M| Vol: 244| 52-wk range: $0.02 – $0.08

Market cap $11.4M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Living Cell Technologies Limited (LVCLY). Living Cell Technologies Limited is a biotechnology company focused on developing regenerative treatments. Their lead product, NTCELL, is in Phase IIb clinical trials for Parkinson's disease.

Last analyzed: Mar 17, 2026
Living Cell Technologies Limited is a biotechnology company focused on developing regenerative treatments. Their lead product, NTCELL, is in Phase IIb clinical trials for Parkinson's disease.

Living Cell Technologies Limited (LVCLY) Healthcare & Pipeline Overview

Employees48
Model self-rating on this text: 79% (not a measure of the evidence) Updated: Mar 17, 2026

Living Cell Technologies Limited ADR Information Unsponsored

Living Cell Technologies Limited (LVCLY) trades in the U.S. as an American Depositary Receipt (ADR).

  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: LVCL

LVCLY OTC Market Information

LVCLY trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy LVCLY shares?

No. LVCLY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for LVCLY elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before LVCLY stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Living Cell Technologies Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.